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Abstract
Background: The anaerobe Clostridium difficile produces two major virulence factors toxin A and B that inactivate Rho
proteins by glucosylation of a pivotal threonine residue. Purified toxins induce reorganization of the cytoskeleton and
cell death in colonic cells. Whether all toxin effects on target cells depend on catalytic glucosyltransferase activity is
unclear at present. Thus, we conducted a proteome approach to compare the protein profile of target cells treated
either with wild type toxin A (rTcdA wt) or with a catalytically inactive mutant toxin A (mutant rTcdA). Relative protein
quantification was feasible using isotope-coded protein labeling techniques (ICPL) and mass spectrometry (LC-MALDI).
Results: Altogether we found a significant differential expression of thirty proteins after treatment with rTcdA wt or
mutant rTcdA. Mutant rTcdA caused up-regulation of seven proteins and sixteen proteins were responsive to rTcdA
wt after 5 h. Long-term effect of rTcdA wt on protein expression was the down-regulation of eleven proteins. Up-
or down-regulation of several proteins was verified by western blot analysis confirming the MS results.
Conclusion: Our results indicate incubation time-dependent effects of the clostridial glucosylating toxin A on
colonic cells. The rTcdA wt impact more cellular functions than actin cytoskeleton reorganization and apoptosis.
Furthermore, these data give insight into glucosyltransferase independent effects of clostridial glucosylating toxins
on target cells after short incubation time. Additionally, our data reveal pro-inflammatory and proliferative effects of
mutant rTcdA after short-term incubation.
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Background
Clostridium difficile is a spore-forming anaerobe, which
produces two major virulence factors, Toxin A (TcdA)
and Toxin B (TcdB) [1]. TcdA and TcdB are the causative
agents of the C. difficile-associated diarrhea (CDAD), a
nosocomial infection with increasing morbidity and mor-
tality due to the emergence of hypervirulent strains [2,3].
Treatment with broad-spectrum antibiotics contributes to
colonization of the colon with toxin producing C. difficile.
The CDAD is characterized by a loss of mucosal barrier
function, secretory diarrhea and colonic inflammation [4].
TcdA and TcdB are homologous single chain toxins
and are composed of an N-terminally located glucosyl-
transferase domain and a large delivery domain. The
latter comprises a receptor binding domain, a transmem-
b r a n ed o m a i na n dac y s t e i n ep r o t e a s ed o m a i n[ 4 ] .T h e
glucosyltranferase domain includes an aspartate-any
amino acid-aspartate motif (D-X-D) and a conserved
tryptophan that participates in the coordination of a man-
ganese ions and the sugar donor UDP-glucose, which are
essential for enzymatic glucosyltransferase activity [1].
The mutation of the D-X-D motif to N-X-N decreases
glucosyltransferase activity by factor of 6,900 compared
to that of wild type recombinant TcdA, so that the
mutant toxin is in fact catalytically inactive [5]. The tox-
ins monoglucosylate the Rho GTPases Rho, Rac, and
Cdc42 and are therefore assigned as clostridial glucosylat-
ing toxins [6]. Rho proteins regulate cell morphology,
gene transcription, and cell proliferation [7]. The inactiva-
tion of Rho, Rac and Cdc42 causes actin depolymerization
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tually leads to cell death (cytotoxic effect).
Several studies reported glucosyltransferase-indepen-
dent effects of TcdA on colonic cells resulting in activa-
tion of mitogen-activated protein kinases, generation of
reactive oxygen species and stimulation of protein
kinases PKC a and b [8-10]. The apoptotic effects have
been assumed to be triggered independently of the gluco-
syltransferase activity.
However, the studies from Gerhard et al.s h o wa
dependence on active TcdA leading to glucosylation of
Rho GTPases for induction of apoptosis [11]. Thus, it is
still unclear, how TcdA renders cells apoptotic. To
further provide insights into these effects we investigated
the changes in protein expression of epithelial colorectal
adenocarcinoma cells (Caco-2) which are targets of Clos-
tridium difficile toxins. The investigated cell line is much
more susceptible to TcdA than to TcdB particular if the
toxin is added from the apical side as obvious in cell cul-
ture plates [12].
To compare different cellular response to wild type
TcdA (rTcdA wt) and enzyme deficient mutant TcdA
(mutant rTcdA) the cytosolic fractions from Caco-2
cells treated with rTcdA wt or mutant rTcdA were ana-
lyzed applying isotope-coded protein labeling (ICPL™).
ICPL is a useful and efficient approach for quantitative
proteomics based on isotope tagging at free lysine resi-
dues and the N-terminus of intact proteins [13,14]. The
complexity of cellular extracts was reduced by means of
one-dimensional SDS-PAGE and reversed phase chro-
matography. Protein identification and quantification
was performed by high resolution mass spectrometry
(MALDI-TOF/TOF-MS) and data base analysis. Our
results indicate biphasic activity of rTcdA wt (short and
long term effects), and evidence is provided that the cat-
alytic inactive toxin modifies the protein profile of colo-
nic cells.
Results
Proteomic analysis of Caco-2 cells
To study the proteome of colonic cells, a large scale
proteome analysis was performed with Caco-2 cells
grown under standard conditions. Protein extracts were
separated by one-dimensional SDS-PAGE and subse-
quently proteins from different gel slices were digested
and the resulting peptides were analyzed using an LC-
MALDI approach. Overall, 2,042 proteins were identi-
fied by at least 2 peptides (Additional file 1). Most of
the identified proteins could be assigned to the cyto-
plasm (844) or the nucleus (533) (Figure 1). 231 proteins
(11%) of the identified proteins are known to appear in
the membrane fraction of cells. Thus, with this techni-
que a comprehensive amount of hydrophobic proteins
could be identified including integrins, cadherins, small
GTPases and various other proteins. A few of the identi-
fied proteins (49) are known to distribute in micro-
somes, cell membrane projection, endosomes,
peroxysomes, lysosomes, centrosomes, and cell junc-
tions. About 144 proteins (7%) are located at the mito-
chondria, 73 proteins (4%) are known to be secreted, 61
proteins (3%) belong to the endoplasmic reticulum, and
29 proteins (2%) are located at the trans-golgi network
in intact cells. The localization of 78 proteins (4%) is
unclear. The function of the identified proteins contrib-
uted to all dominant cellular activities such as growth,
proliferation, motility, adhesion, protein transport, signal
transduction, metabolism, cell cycle control, transcrip-
tion, and translation. Some of the identified proteins, e.
g. IgGF-binding protein, Cytokeratin-18, Src substrate
cortactin are typically overexpressed in colorectal adeno-
carcinoma cells [15].
Treatment of Caco-2 cells with rTcdA wt and mutant
rTcdA
Different toxin concentrations were tested to ensure that
Caco-2 cells responded strongly to the clostridial toxins
but remain viable. Optimal conditions were achieved
when cells near confluence were treated with 0.5 μg/ml of
rTcdA wt or mutant rTcdA for 5 h and 24 h (Figure 2).
Cells treated with rTcdA wt started to round up after 2 h
and after 5 h 70% and after 24 h nearly all Caco-2 cells
rounded up as a result of the cytopathic activity of rTcdA
wt. In contrast, control cells or cells treated with mutant
rTcdA did not show any cell rounding and had a similar
morphology. To confirm toxin activity, western blot analy-
sis of cell lysates was performed using a Rac1 specific anti-
body that only recognizes non-glucosylated Rac1. The
Figure 1 Analysis of the Caco-2 proteome.Caco-2 cells were
harvested after reaching confluence, lysed and proteins were
isolated. LC-MALDI-TOF/TOF analysis was performed after in-gel
digestion of 200 μg of proteins from whole cell lysate. More than
2,000 proteins were identified and can be ordered to different cell
compartments. The percentage of identified proteins for ER,
secreted or unknown localization is given. The proteins of
microsomes, cell junction, cell projection, endosomes, peroxisomes,
lysosomes and centrosomes are summarized and named as other.
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Page 2 of 12intracellular activity of rTcdA wt resulted in a decreasing
concentration of nonglucosylated Rac1 visualized by inten-
sity of the Rac1 band (Figure 3). In control cells and cells
treated with mutant rTcdA only non-glucosylated Rac1
was present, whereas Rac1 from the cells treated with
rTcdA wild type was not detected because it was comple-
tely glucosylated by the toxin.
Quantitative proteomic analysis of Caco-2 cells treated
with rTcdA wt and mutant rTcdA, respectively, for 5 h
To estimate the variation of the ICPL technique equal
amounts of proteins from control cells were labeled with
the duplex reagent in a 1:1 ratio. Mass spectrometric ana-
lysis was performed for three technical replicates (data not
shown). The protein load was normalized by comparing
the intensities of all analyzed peptides leading to normali-
zation factors of 1.2 at maximum. The variability of this
quantification method was determined for all labeled pro-
teins to be between 1.4 and 0.7, the mean standard devia-
tion was 0.22. Therefore, proteins with regulation factors
above 1.4 were assigned as up-regulated and below 0.7 as
down-regulated.
Proteins of the cytosolic fraction of control cells were
obtained and two biological replicates were prepared
and labeled. Cells treated for 5 h with rTcdA wt, and
mutant rTcdA were labeled with heavy and medium
ICPL-reagent. Untreated control cells were labeled with
the light ICPL version. Subsequently, proteins were
combined and analyzed. Overall, 152 different proteins
were identified that had been quantified by at least 2
labeled peptides. It was carefully checked whether for
ICPL-labeled peptides corresponding unlabeled peptides
were present. No unlabeled peptide was detected if a
labeled one was present. This analysis revealed the iden-
tification of 327 proteins by at least two unique peptides
from the cytoplasm of Caco-2 cells and quantification of
278 proteins by at least one unique peptide.
False discovery rates for two replicates were 0.7% and
0.74% with p < 0.05. Based on normalization seven pro-
teins in Caco-2 cells were up-regulated in response to
treatment with mutant rTcdA (Table 1, Figure 4A, Addi-
tional file 2). The rTcdA wt treatment induced up-regula-
tion of five proteins and down-regulation of eleven
proteins in Caco-2 cells (Table 1, Figure 4B, Additional
file 2). However, different proteins were responsive to
rTcdA wt or mutant rTcdA treatment. Slight differences
were observed in retention time for the deuteriumcontain-
ing ICPL reagents. To overcome this problem the reten-
tion time tolerance was set to 4-times fractionation size in
the WARP-LC method.
The quantitative MS data for the proteins Rac1 and
clathrin heavy chain 1 provided evidence for an up-regu-
lation after treatment with both rTcdA wt and mutant
rTcdA. Since not enough peptides for these proteins
could be quantified, the statistical tests (n ≤ 3) failed to
show significance and the proteins were not included in
the list of regulated proteins. However, clathrin is
involved in TcdA uptake and Rac1 belongs to the main
targets of TcdA in the cytoplasm. Thus, particular atten-
tion was paid to these two proteins and the MS analysis
was additionally verified by western blot analysis using
specific anti-clathrin heavy chain 1 and anti-Rac1 antibo-
dies (see below).
Quantitative proteome analysis of Caco-2 cells treated
with rTcdA wt and mutant rTcdA, respectively, for 24 h
Cytosolic proteins from control cells and cells treated
with either rTcdA wt or mutant rTcdA were labeled with
light, heavy, and medium ICPL-reagent, respectively.
Two technical replicates of the first biological replicate
and one technical replicate from the second biological
replicate were prepared and analyzed. 485 proteins were
identified by at least two unique peptides, 420 proteins
were quantified by at least one unique peptide and 286
proteins were quantified by at least two unique peptides.
The false discovery rates for all replicates were 1.05%,
1.16% and 0.83% with p < 0.05. Eleven proteins were sig-
nificantly down-regulated by rTcdA wt and one of them,
filamin A, was down-regulated after treatment with
mutant rTcdA, too (Table 1, Figure 4C, Additional
Figure 2 Cytopathic effect of toxin A on Caco-2 cells.C a c o - 2
cells were treated with 500 ng/ml recombinant toxin A wild type or
with mutant recombinant toxin A in DMEM medium. Caco-2 cells
were document before (0 h) and after 5 h or 24 h of toxin A
treatment.
Figure 3 rTcdA glucosylates Rac-1 in Caco-2 cells.T h e
cytopathic effect was shown by a Rac-1 glucosylation sensitive
western blot analysis. The used antibody did not bind to
glucosylated Rac-1. 1 and 4: control cells; 2 and 5: rTcdA wt treated
cells; 3 and 6: mutant rTcdA treated cells.
Jochim et al. Proteome Science 2011, 9:48
http://www.proteomesci.com/content/9/1/48
Page 3 of 12Table 1 Regulated proteins in Caco-2 cells after treatment with rTcdA wt or mutant rTcdA using ICPL-LC-MS-technique
after treatment with mutant rTcdA, 5
h
Nr. Protein name Accession
number
Gene
name
Number of peptides for
quantitation
regulation factor
1 SD
2 T-test
3
1 Acetyl-CoA acetyltransferase, cytosolic
variant
Q9BWD1 ACAT 2 8 2.39 0.53 0.047
2 Alpha-enolase P06733 ENO1 3 1.96 0.31 <0.0001
3 Annexin A3 P12429 ANXA3 5 1.59 0.22 0.015
4 Glucosamine–fructose-6-phosphate
aminotransferase
Q06210 GFPT1 4 1.79 0.51 0.005
5 Macrophage migration inhibitory factor P14174 MIF 6 1.59 0.35 0.042
6 Peroxiredoxin-1 Q06830 PRDX2 10 1.75 0.36 0.001
7 Peroxiredoxin-2 P32119 PRDX1 6 1.76 0.14 0.003
after treatment with rTcdA wt, 5 h
Nr. Protein name Accession
number
Gene
name
Number of peptides for
quantitation
regulation factor SD T-test
1 40S ribosomal protein S16 P62249 RPS16 3 0.38 0.07 0.01
2 40S ribosomal protein S17 P08708 RPS17 9 0.40 0.03 0.018
3 40S ribosomal protein S3 P23396 RPS3 5 0.35 0.02 0.004
4 40S ribosomal protein S9 P46781 RPS9 9 0.33 0.04 0.003
5 60S ribosomal protein L18 Q07020 RPL18 8 0.36 0.07 0.007
6 60S ribosomal protein L18a Q02543 RPL18A 4 0.33 0.05 0.004
7 60S ribosomal protein L8 P62917 RPL8 5 0.22 0.02 0.024
8 60S ribosomal protein L9 P32969 RPL9 6 0.36 0.01 0.04
9 Glutamate dehydrogenase 1,
mitochondrial
P00367 GLUD1 7 0.54 0.02 0.042
10 Heterogeneous nuclear
ribonucleoprotein A1
P09651 HNRNPA1 8 0.50 0.11 0.024
11 Polypyrimidine tract-binding protein 1 P26599 PTBP1 5 0.57 0.2 0.03
12 Glucosidase 2 subunit alpha Q14697 GANAB 19 1.76 0.13 <0.0001
13 Glucosidase 2 subunit beta P14314 PRKCSH 6 1.95 0.04 0.038
14 Endoplasmin P14625 HSP90B1 32 1.72 0.04 <0.0001
15 Protein disulfide-isomerase P07237 P4HB 21 1.80 0.28 0.008
16 Protein disulfide-isomerase A4 P13667 PDIA4 10 1.65 0.3 0.0003
after treatment with mutant rTcdA,
24 h
Nr. Protein name Accession
number
Gene
name
Number of peptides for
quantification
regulation factor SD T-test
1 Filamin A P21333 FLNA 4 0.7 0.06 0.015
after treatment with rTcdA wt, 24 h
Nr. Protein name Accession
number
Gene
name
Number of peptides for
quantification
regulation factor
(average)
SD T-test
3
1 Actin, cytoplasmic 1 P60709 ACTB 46 0.57 0.25 <0.0001
2 Filamin A P21333 FLNA 4 0.52 0.04 0.01
3 Filamin B O75369 FLNB 65 0.6 0.14 <0.0001
4 Villin-1 P09327 VIL1 11 0.58 0.19 0.008
5 Apolipoprotein E P02649 APOE 4 0.29 0.00 0.041
6 Creatine kinase B-type P12277 CKB 23 0.57 0.04 <0.0001
7 Glucosidase 2 subunit beta P14314 PRKCSH 11 0.46 0.09 0.007
8 Peroxiredoxin-1 Q06830 PRDX1 22 0.72 0.14 <0.0001
9 Peroxiredoxin-2 P32119 PRDX2 15 0.63 0.11 0.004
10 Peroxiredoxin-6 P30041 PRDX6 6 0.58 0.04 0.026
11 Annexin A3 P12429 ANXA3 11 0.68 0.13 0.006
1 The change in abundance of the proteins is expressed by the calculated ratio between with rTcdA wt or mutant rTcdA treated cells and control cells of all
labeled peptides and the average ratio was determined.
2 SD: standard deviation
3 T-test: Student’s t-test was used for calculation of p-values, p < 0.05
Jochim et al. Proteome Science 2011, 9:48
http://www.proteomesci.com/content/9/1/48
Page 4 of 12A
0
0.5
1
1.5
2
2.5
3
3.5
ACAT 2 ENO1 GFPT1 MIF ANXA3 PRDX2 PRDX1
F
o
l
d
 
r
e
g
u
l
a
t
i
o
n
+ mutant rTcdA vs control cells + rTcdA wt vs control cells
*
*
* * **
**
***
B
0
0.5
1
1.5
2
2.5
F
o
l
d
 
r
e
g
u
l
a
t
i
o
n
+ mutant rTcdA vs control cells + rTcdA wt vs control cells
** ** ** * * *
*
*
*
*
*
*
*** ***
*** **
0
0.5
1
1.5
2
2.5
F
o
l
d
 
r
e
g
u
l
a
t
i
o
n
+ mutant rTcdA vs control cells + rTcdA wt vs control cells
*** ***
***
***
** **
**
** **
*
* *
C
Figure 4 Regulated proteins in Caco-2 cells after treatment with rTcdA wt or mutant rTcdA. The regulation factors were calculated from
all peak area of peptides identified for each protein and normalized to correct protein load. Statistical evaluation was performed using GraphPad
Prism 5 (GraphPad Software, Inc.). Bars represent mean ± SD; *, p < 0.05, **, p < 0.001, ***, p > 0.0001 versus control cells. For each protein the
corresponding regulation factor of mutant rTcdA or rTcdA wt approach is shown. A) After 5 h of treatment with mutant rTcdA; B) After 5 h of
treatment with rTcdA wt; C) After 24 h of treatment with rTcdA wt or with mutant rTcdA.
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Page 5 of 12file 2). Due to high similarities actin isoforms, beta-actin
and gamma-actin, could not be distinguished by mass
spectrometric analysis, thus both isoforms were supposed
to be down-regulated in response to rTcdA wt. Four pro-
teins were similarly regulated by both, rTcdA wt and
mutant rTcdA but due to a limited amount of detectable
ICPL-labeled peptides the quantitative data were just
below statistical significance (data not shown). In all
cases only one peptide that was labeled with the light,
medium and heavy ICPL reagent was detectable. Three
of these proteins, glutathione S-transferase A2, annexin
A4 and Rac1 might be up-regulated whereas one protein,
mitsugumin23, might be down-regulated. Thus, a wes-
tern blot analysis was done at least for Rac1 using specific
antibodies (see below).
Verification of quantitative proteome data by Western
Blot analyses
Western blot analyses were performed in order to verify
t h eq u a n t i t a t i v ep r o t e o m ed a t ao b t a i n e db yt h eI C P L
experiments. The proteins endoplasmin (HSP90B1), gluco-
sidase 2 subunit beta (PRKCSH), creatin kinase B (CKB),
and apolipoprotein E (Apo-E) were selected for these
further investigations. All these proteins showed a consid-
erable regulation as detected using the ICPL technique.
Rac1 and clathrin heavy chain (CLH-17) whose regulation
was just below the significant threshold as evident after
ICPL based analysis (s. above) were additionally quantified
by Western bot analysis (Figure 5). Quantitative results
obtained for endoplasmin and apolipoprotein E were con-
sistent with the quantitative proteome data as shown in
Figure 5A, D. Some discrepancies were observed using
anti-glucosidase 2 subunit beta and anti-creatin kinase B-
type antibodies (Figure 5B, C). Glucosidase 2 subunit beta
seemed to be up-regulated by 2-fold after treatment with
mutant rTcdA for 24 h, whereas ICPL data showed no
changes in protein expression of glucosidase 2 subunit
beta under these conditions. However, in cells treated with
rTcdA wt the analyses using antibodies against glucosidase
2 beta fit well to the quantitative mass spectrometry data.
The western blot analyses for creatin kinase B-type also
indicated differences to the ICPL-based mass spectrometry
data for the 5 h time point. Under these conditions crea-
tine kinase B-type was found up-regulated by western blot
analysis after treatment with mutant rTcdA but no regula-
tion was detected using ICPL analysis (Figure 5C). The
data acquired for apolipoprotein E after 24 h treatment
with rTcdA wt and mutant rTcdA corresponded well to
the western blot results. After 5 h treatment with rTcdA
wt or mutant rTcdA apolipoprotein E was not detected by
mass spectrometry; however the protein was clearly
detected by western blot analysis and showed no signifi-
cant changes at protein level after 5 h in the cytosolic frac-
tion. The proteins clathrin heavy chain 1 and Rac1 were
clearly identified by the mass spectrometry approach but
no statistical indications for an up-regulation were found
by the ICPL analysis, because only one peptide of each
protein was labeled by the heavy, medium, and light ICPL-
reagent (s. above). However, western blot analyses proved
an up-regulation of these proteins. In the Figure 5E and
5F the values of the ICPL-labeled single peptide and the
data from western blot analysis are shown.
Discussion
The main virulence factors of C. difficile are the toxins
TcdA and TcdB that inactivate Rho proteins in eukaryo-
tic cells. The toxins act in the cytosol of target cells to
catalyze the transfer of a glucose moiety onto a crucial
threonine residue of Rho proteins. Delivery of the toxins
into the cytosol and their effects on Rho proteins and
Rho-dependent signaling in host cells is investigated [4,7]
but proteins and pathways involved in processes down-
stream of Rho proteins are largely unclear at present. In
particular, the question whether large clostridial cytotox-
ins affect target cells independently of the intrinsic gluco-
syltransferase activity and thus independently of Rho
proteins is controversially discussed [4,16]. Hence we
initiated a toxicoproteomic study to analyze cellular
effects of large clostridial cytotoxins using recombinant
wild type or mutant TcdA. A similar study has been con-
ducted to elucidate the function of the C3 exoenzyme of
C. botulinum where several proteins were identified to be
responsive to C3 treatment in neuronal cells [17]. Thus,
a comprehensive proteome analysis was conducted using
the ICPL technique and LC-MALDI-MS. ICPL labeling
occurs at lysine residues and prevents trypsin cleavage
after these residues. Thus, the tryptic digestion was
altered to an ArgC specificity leading to the generation of
slightly larger peptides on average. However, quantifica-
tion was only possible for half of the identified proteins.
Although lysine is overrepresented in human proteins
(>7%), several of the identified peptides did not contain
lysine residues. Additionally, few lysine residues remained
unlabeled at all or escaped labeling. For these peptides
containing unlabeled lysine residues no corresponding
peptides with a labeled lysine were detected. Also the
opposite was not observed: for all identified ICPL-labeled
peptides no unlabeled counterpart was detected. From
this observation we concluded that ICPL labeling is either
complete or completely lacking for a particular peptide.
Overall 30 proteins responded to the treatment with
rTcdA wt or mutant rTcdA (Figure 4). Short time effects
(5 h) were responsible for up- or down-regulation of six-
teen proteins due to treatment with rTcdA wt; seven pro-
teins were identified by mass spectrometry as up-regulated
by mutant rTcdA (Figure 4A, B). Moreover, two proteins,
Rac1 and clathrin heavy chain 1, were up-regulated by
both rTcdA wt and mutant rTcdA as determined by MS
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Figure 5 Western blot analyses of regulated proteins. Caco-2 cells were treated with rTcdA wt or mutant rTcdA (500 ng/mL) for 5 h or 24 h.
After fractionation the cytosolic proteins were separated on 12% SDS-PAGE and probed with antibodies against regulated ptoteins. The western
blot quantitation was performed on a Kodak Image Station 440 CF by analysis with the Kodak 1D Image software, for normalization of samples
a-tubulin was used. The bars represent fold regulation factors referred to values of control samples (mean values + SD, n ≥ 3). The mass
spectrometry data of corresponding proteins were shown to compare the results of this study. A) Endoplasmin (HSP90B1); B) Glucosidase 2
subunit beta (PRKCSH); C) Creatin kinase b-type (CKB); D) Apolipoprotein E (ApoE); E) Rac1; F) Clathrin, heavy chain 1 (CLH-17).
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Page 7 of 12and western blot techniques (Figure 5E, F). After long time
treatment (24 h) with rTcdA wt, the concentration of ele-
ven proteins was altered (Figure 4C). Additionally, one of
the latter proteins, filamin A (FLNA), was significantly
down-regulated after treatment with mutant rTcdA.
These data strongly indicate particular effects of the cata-
lytic inactive mutant rTcdA. This provides further evi-
dence that large clostridial cytotoxins alter cellular
processes of target cells independently of the intrinsic glu-
cosyltransferase activity. Additionally, cellular processes
independent from cytoskeleton homeostasis are influenced
by the clostridial cytotoxins.
Short-time transferase-independent effects of toxins
include changes in concentration of proteins involved in
energy metabolism and signal transduction. Interestingly,
annexin A3 (ANXA3) and the pro-inflammatory cytokine
macrophage migration inhibitory factor (MIF) were up-
regulated, which are known to be involved in response to
bacterial pathogens [18,19]. These proteins were not up-
regulated in the cells treated with rTcdA wt for 5 h, but
rTcdA wt induces down regulation of annexin A3 after
24 h (Figure 4C). MIF suppresses pro-oxidative stress-
induced apoptosis and contributes to the regulation of cell
survival [20]. Thus, mutant rTcdA signaling further facili-
tates cell proliferation of Caco-2 cells and should be clearly
different from that of rTcdA wt. Rac1 is a major target of
rTcdA wt and was up-regulated after treatment with wild
type as well as with mutant toxin. Thus, Rac1 up-regula-
tion facilitated via a Rho-independent signaling pathway
that might also adjust up-regulation of MIF, annexin A3,
clathrin heavy chain 1, peroxiredoxins, metabolic enzymes,
and probably other so far unrecognized proteins. Up-regu-
lation of Rac1 and other proteins by the catalytic inactive
toxin might be interpreted as a protection response of the
colonic cells that is induced by so far unknown mechan-
isms or a general effect related to endocytotic uptake of
toxin. Thus, Rho-independent signal transduction
mechanism might be responsible to detect and respond to
bacterial infections. Another cellular target of rTcdA wt,
RhoB, is well known to be up regulated in response to
TcdA wt treatment but is not induced by the catalytic
inactive rTcdA mutant. RhoB induction is thought to have
a proapoptotic function [11,21].
Caco-2 cells treated for 5 h with rTcdA wt responded
in a considerable decrease of ribosomal proteins that are
involved in ribosome function and mRNA trafficking
[22]. However, ribosomal proteins possess extra-riboso-
mal functions [22,23]. The 40S ribosomal protein S3
(RPS3) is involved in maturation of 40S ribosomal subu-
nit and exhibits apoptotic function [24,25]. Lee et.al.
have shown, that RPS3 phosphorylated by Akt accumu-
lates in the nucleus possesses reduced proapoptotic prop-
erties [26]. The proteins glutamate dehydrogenase 1,
mitochondrial (GLUD1), heterogeneous nuclear
ribonucleoprotein A1 (hnRNPA1), and polypyrimidine
tract-binding protein 1 (PTBP1) were down regulated
after short term rTcdA wt treatment (Figure 4B). The lat-
ter two proteins are also involved in mRNA metabolism,
processing, and transport [27-30]. HnRNP A1 becomes
localized in the cytoplasm upon transcription inhibition
and belongs to transcription-sensitive group of hnR pro-
teins. The hnRNPA1 shuttling activity is required for sur-
vival and granulocytic differentiation of normal myeloid
precursors [31,32]. The cellular distribution upon tran-
scription inhibition of PTBP1 is transcription-insensitive;
the protein is localized in the nucleus [33]. The reduced
concentration of ribosomal proteins was identified in the
cytoplasmic protein fraction and might indicate a more
nuclear localization of these proteins that can reside in
both, the nuclear and the cytoplasmic compartment.
Thus, a disruption of the balanced shuttling between
cytoplasm and nucleus can be assumed due to the treat-
ment with rTcdA wt. However, after 24 h treatment of
Caco-2 cells with rTcdA wt no changes in expression of
the ribosomal proteins, hnRNPA1, and PTBP1 were
observed. Thus, the down-regulation of these proteins in
cytosol is terminated as an early effect of the clostridial
cytotoxins.
Protein glucosidase 2 (alpha and beta subunit,
GANAB and PRKCSH), the chaperons endoplasmin
(HSP90B1), protein disulfide-isomerases (P4HB and
PDIA4) were induced after 5 h treatment with rTcdA
w t .( F i g u r e4 B ,5 A ,B ) .E n d o p l a s m i ni sag l y c o p r o t e i n
[34] that has been linked to the Toll-like receptor path-
way [35], response to hypoxia [36], and this protein is
required for innate immunity but not cell viability [37].
It forms a large chaperone multiprotein complex with
protein disulfide-isomerase A4 and other chaperonins
and is essential for translocation of C. botulinum C2
toxin and uptake of C. perfringens iota toxin into eukar-
yotic cells [38,39]. Indeed, endoplasmin has been
reported to bind to TcdA at the cell surface and is
translocated together with TcdA into the cytoplasm
[40]. We propose that toxin-dependent endoplasmin
translocation from membrane into the cytoplasma led to
an increased cytoplasmic concentration of this protein
that was not observed after treatment with mutant
rTcdA.
Glucosidase 2 beta catalyzes the removal of three glucose
residues from the peptide-bound Glc3-Man9-GlcNAc2 oli-
gosaccharide remodelling the asparagine-linked precursor
[41] and UDP-glucose:glycoprotein glycosyltransferase.
The latter plays a possible role in control of protein glyco-
sylation [42] and regulation of N-glycoprotein transport or
protein degradation [43,44]. These data indicate that post-
translational modifications like glycosylation are influenced
by large clostridial toxins. However, after 24 h treatment
with rTcdA wt glucosidase 2 beta decreased by 2-fold.
Jochim et al. Proteome Science 2011, 9:48
http://www.proteomesci.com/content/9/1/48
Page 8 of 12After the long-term treatment of cells with rTcdA wt
several cytoskeletal proteins (beta-, gamma-actin, filamine
A and B, villin 1) were down regulated. This is in good
accordance to the cytopathic cell rounding of rTcdA wt
treated cells. Interestingly, filamine A was also down-regu-
lated by rTcdA mutant. Thus, a Rho-independent signal-
ing should be involved in filamine regulation.
Peroxiredoxins 1, 2, 6 were found down-regulated after
treatment with rTcdA wt for 24 h; peroxiredoxins 1 and
2 were up-regulated after short time incubation with
mutant rTcdA (Figure 4A, C). Kim et.al.r e p o r t e dt h a t
C. difficile Toxin A induces the release of reactive oxygen
species (ROS) and influences the regulation of cyclooxi-
genase-2 and prostaglandin E2 synthesis by ROS [9,45].
The expression changes of peroxiredoxins are involved in
redox control and might be induced after 5 h to protect
cells from ROS. Down regulation of these protecting
enzymes after 24 h of toxin treatment might be a hint
that the cells have become more apoptotic.
The presented data indicate that large clostridial cyto-
toxins like TcdA act not only on Rho proteins and induce
Rho-dependent pathways. Rho-independent effects
evoked by a catalytic inactive toxin mutant point to new
cellular target structures in eukaryotic cells and so far
unknown ways of signaling. For the first time evidence
has been provided that TcdA influences more cellular
functions than cytoskeleton homeostasis and apoptosis.
The response of colonic cells to TcdA is time-dependent
and different protein patterns are evident after short
(5 h) and long (24 h) incubation times. Activity and prob-
ably location of ribosomal proteins, metabolic enzymes,
and protection enzymes like peroxiredoxin were modified
due to action of TcdA.
Materials and methods
Cell culture and preparation of cellular fractions
Caco-2 cells were grown in Dulbecco’s minimum essen-
tial medium (DMEM) containing 10% fetal calf serum
(FCS), 100 U/ml penicillin and 0.1 mg/ml streptomycin
and 1% non-essential amino acids and were maintained
at 37°C in an atmosphere of 5% CO2 in air. Cells were
subcultured twice a week and cells were grown for one
day before treatment with rTcdA wt or mutant rTcdA
that was deficient in glucosyltransferase activity [5]. The
toxins were added to the medium in a concentration of
0.5 μg/ml (0.0016 mM). After 5 h or 24 h the medium
was removed and cells were washed three times with
PBS. Two biological replicates for 5 h and for 24 h sam-
ples were produced. The cells were scratched from the
culture flasks with a cell scraper and resuspended in 1 ml
of buffer A (10 mM HEPES, pH 7.9, 10 mM KCl, 300
mM sucrose, 1.5 mM MgCl2, 0.1% NP-40, 0.5 mM
PMSF, 0.04% 25 × Complete EDTA-free) and cytosolic
and nuclear protein preparation were performed as
described [46]. Briefly, after incubation on ice for 5 min-
utes cell lysates were centrifugated (13 200 rpm for
30 second), so the supernatant contained cytosolic pro-
teins. Nuclear pellet was washed by resuspending in buf-
fer A and centrifugated, as well. Eventually, the nuclei
were resuspended in 100 μL buffer B (20 mM HEPES,
pH 7.9, 100 mM KCl, 100 mM NaCl, 0.5 mM PMSF, 20%
(v/v) glycerol, 0.04% (v/v) 25 × Complete EDTA-free),
sonicated for 10 seconds and centrifugated (13.200 rpm
for 30 second). Quality of the separation was controlled
by western blotting using lamin B and GAPDH as marker
proteins. Protein concentration was determined using
Bradford assay. The protein extracts were stored at -80°C.
Preparation of toxins
All experiments were performed with purified, recombi-
nant wildtype TcdA and glucosyltransferase deficient
mutant TcdA expressed in Bacillus megaterium expres-
sion system. The His-tagged fusion proteins were puri-
fied by Ni2+ affinity chromatography [47]. The tcdA
gene from C. difficile strain VPI 10463 (GenBank acces-
sion no. X51797) was used for overexpression. Purity
and protein concentration of the overexpressed protein
were controlled and the activity was monitored by
toxin-induced cell rounding. The absence of cytotoxic
impurities acting on isolated mitochondria was checked
using a cytochrome C release assay as described pre-
viously [47,48].
ICPL-labeling of cytosolic proteins and in-gel digestion
Before ICPL-labeling procedure acetone precipitation of
proteins from each biological replicate were carried out.
To one volume of sample 5 volumes of acetone cooled to
-20°C were added and incubated over night at -20°C. Pre-
cipitated proteins were pelleted by centrifugation at
15,000 g at 4°C and 15 min. Pellets were washed with
cold 80% (v/v) aceton (-20°C) and dried. Proteins were
solved in ICPL lysis buffer containing Guanidine-HCl,
protein concentration was determined using Bradford
assay and the concentration was adjusted to 5 mg/ml by
adding ICPL Lysis buffer. Equal amounts (100 μg) of
cytosolic proteins of untreated Caco-2 cells, Caco-2 cells
treated with rTcdA wt or Caco-2 cells treated with
mutant rTcdA were labeled with ICPL™-Triplex reagent
using the ICPL™ kit from Serva Electrophoresis GmbH
(Heidelberg, Germany) as described by the manufacturer
[49]. First, the cysteine residues were reduced using
0.5 μl of reduction solution (TCEP-HCl, tris(2-carbox-
ethy1)phosphine, 200 mM) and alkylated using 0.5 μLo f
400 mM iodoacetamide (IAA). To label the N-terminus
and free amino groups at the lysine residues 3 μLo fC
12-
or C
13 or D
2 - nicotinoyloxysuccinimide (Nic-reagent)
were added to each mixture and incubated for 3 h in the
dark. Thereafter all three ICPL labeled samples were
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remove excess labeling reagent (as described above). Pro-
teins were solved in Laemmli sample buffer, separated by
gradient SDS-PAGE (8.5%-18%) and stained with Coo-
m a s s i eb r i l l i a n tb l u e .T h eg e ll a n ew a sc u ti n t o2 0 - 2 5
pieces and in-gel digestion was performed; proteins were
destained with 50 mM NH4HCO3 in 50% (v/v) acetoni-
trile (ACN) [50]. Then the gel pieces were dried with
100% ACN, vacuum evaporated and rehydrated with
20 μLo f5n g / μL modified trypsin (Promega) in 20 mM
NH4HCO3,1 0 %A C N .A f t e ri n c u b a t i o no ni c ef o r1h ,
residual trypsin solution was removed and substituted by
20 mM NH4HCO3 in 10% ACN. The digestion was per-
formed over night at 37°C. Supernatants were collected
and the gel pieces were washed with 50% ACN in 0.2%
(v/v) TFA and then dried in 10% (v/v) ACN. All superna-
tant containing peptides were pooled and dried. The
dried peptide samples were stored at -80°C until analysis.
For separation by high performance liquid chromatogra-
phy (HPLC) samples were dissolved in 100 μL2 %( v / v )
ACN in 0.1% (v/v) TFA.
Liquid chromatography
Peptide separation was done by reversed phase chromato-
graphy using a nano-HPLC system (Dionex GmbH,
Idstein, Germany) which consists of an autosampler
(Famos), a loading pump (Switchos), a gradient pump
(Ultimate) and a microfraction collector (Probot). An ali-
quot of 20 μL of each sample was injected onto a C18 trap
column (PepMap 300 μm × 5 mm, 3 μm, 100 Å, Dionex)
with 2% (v/v) acetonitrile in 0.1% (v/v) TFA at a flow rate
of 30 μL/min. After switching the trap column into the
nanoflow (200 nL/min), the peptides were eluted onto a
separation column (PepMap, C18 reversed phase material,
75 μm × 150 mm, 3 μm, 100 Å, Dionex GmbH, Idstein,
Germany) and separated at a flow rate of 200 nL/min
using eluent A with 5% (v/v) acetonitrile in 0.1% (v/v)
TFA and eluent B with 80% (v/v) acetonitrile in 0.1% (v/v)
TFA with a gradient from 10% to 40% (v/v) eluent B in
134 min and 40% (v/v) to 100% (v/v) eluent B in 10 min.
384 fractions of 94 nL and spotting time of 23 s were
spotted directly onto a manually prespotted MALDI
Anchor Chip 600/384 target plate (Bruker Daltonics
GmbH, Bremen, Germany) with a continuous sheath flow
of 2.5 μL/min 5% (v/v) acetonitrile in 0.1% (v/v) TFA.
MALDI TOF/TOF
For target preparation the a-cyano-4-hydroxy-cynnamic
acid (CHCA) matrix composed of 4 mg/ml CHCA in
50% (v/v) acetonitrile, 0.1% (v/v) TFA was diluted 1:4 and
0.6 μL of this matrix solution was spotted on each spot of
a MALDI Anchor Chip 600/384 target plate. After sam-
ple spotting recrystallization was performed with 0.2 μL
of 5% (v/v) acetonitrile and 0.1% (v/v) TFA. For external
calibration 0.3 μL of peptide calibration standard (Bruker
Daltonik GmbH) was spotted onto the target calibration
spots. Mass spectra were recorded with an Ultraflex
TOF/TOF I mass spectrometer (Bruker Daltonics
GmbH, Bremen, Germany) operating with FlexControl
2.4, FlexAnalysis 2.4, BioTools 3.0 and WARP-LC 1.1
software. To identify proteins, searches against the
MSDB database (version 2007, 148 210 sequences for
human) using Mascot 2.2 software (Matrix Science, in-
house server) were carried out. For FDR calculation the
BTTask.tas of each run was converted to .mgf by soft-
ware programm TasFileMGFExporter (provided by Bru-
ker Daltonik GmbH), all .mgf files from one sample were
combined by Notepad++ v.5.6.8, and automatic decoy
searches against MSDB data base using Mascot 2.2 were
performed. Searches were performed considering variable
modifications like oxidation of methionin, carbamido-
methylation of cysteins and ICPL modifications. One
missed cleavage was allowed and the mass tolerance was
s e tt o< 1 0 0p p mf o rp r e c u r s o ri o n sa n d≤ 70 ppm for
fragment ions. Peptides were termed identified if the pep-
tide ion score was > 25 and proteins were identified with
at least two unique peptides. Decoy database searches
were performed with the MSDB random database and
the same parameters as described above to define the
false discovery rate. To calculate the heavy/light (H/L) or
medium/light (M/L) ratios of a protein at least two
unique peptides labeled with heavy medium and light
reagent were chosen and the average ratio was deter-
mined. Mass spectral data are available under accession
number 18334-18339, PRIDE database [51].
Western blot
Mouse monoclonal anti-Rac1 (clone 23A8) was pur-
chased from Millipore (Billerica, USA), mouse monoclo-
nal anti-GAPDH was from Zytomed systems (Zytomed
systems GmbH, Germany), mouse monoclonal anti-Rac1
(Clone 102) and mouse anti-Clathrin heavy chain 1 were
from BD Transduction Laboratories (Erembodegem,
Belgium), mouse monoclonal anti-a-Tubulin, rabbit
polyclonal anti-Creatine kinase B-Type and rabbit poly-
clonal anti-HSP90B1 were from Sigma (Saint Louis,
USA), mouse monoclonal anti-Glucosidase IIb (D-1) and
goat polyclonal anti-Lamin B were from Santa Cruz Bio-
technology (Santa Cruz, USA) and mouse monoclonal
anti-Apolipoprotein E was from MBL (Naka-Ku Nagoya,
Japan). For the analysis of complete lysates or cytosolic
proteins by SDS-PAGE and Western blotting, samples
were dissolved in Laemmli sample buffer, incubated at
95°C for 5 min and loaded onto the gel [52]. Proteins
were separated on 15, 12, or 7.5% polyacrylamide gels
with 5% stacking gel. For Western blotting, proteins were
transferred onto nitrocellulose membranes by a semi-dry
blot system (Trans-Blot
® SD Semi Dry, BioRad
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Page 10 of 12Laboratories) for 72 min at 17 V using 25 mM Tris, 192
mM glycine buffer containing 20% (v/v) methanol. The
membranes were blocked with 5% (w/v) non fat dried
milk in TBST (50 mM Tris, pH 7.2, 150 mM NaCl, 0.05%
(v/v) Tween 20) for 60 min and incubated with primary
antibody over night at 4°C. Primary antibodies were
probed with the horseradish peroxidase-conjugated sec-
ondary antibodies at room temperature for 60 min and
detected by enhanced chemiluminescence reaction
Femto (Pierce, Thermo Fisher Scientific Inc., Rockford,
IL, USA). The western blot quantitation was performed
on a Kodak Image Station 440 CF by analysis with the
Kodak 1D Image software.
Statistical analysis
The two sided Student’s t-test was performed to
describe significant regulation using peakareas of the
entire isotopic cluster of labeled peptides. A value of p <
0.05 was accepted as significant and assigned with
asterics. The t-test was only used for studies with n ≥ 3
peak areas. All values are given as mean values ± stan-
dard deviation.
Additional material
Additional file 1: Identified proteins in Caco-2 cells using LC-MALDI-
technique.
Additional file 2: A summary of regulated proteins in Caco-2 cells
after treatment with rTcdA wt or mutant rTcdA.
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